ERYTHROMYCIN LACTOBIONATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for erythromycin lactobionate and what is the scope of freedom to operate?
Erythromycin lactobionate
is the generic ingredient in three branded drugs marketed by Abbott, Hospira, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Exela Pharma, Nexus, and Teva Parenteral, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.Three suppliers are listed for this compound.
Summary for ERYTHROMYCIN LACTOBIONATE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 8 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 5 |
Patent Applications: | 2,692 |
What excipients (inactive ingredients) are in ERYTHROMYCIN LACTOBIONATE? | ERYTHROMYCIN LACTOBIONATE excipients list |
DailyMed Link: | ERYTHROMYCIN LACTOBIONATE at DailyMed |
Recent Clinical Trials for ERYTHROMYCIN LACTOBIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prof Dr Jan Tack | N/A |
Cempra Inc | Phase 2/Phase 3 |
Biomedical Advanced Research and Development Authority | Phase 2/Phase 3 |
Pharmacology for ERYTHROMYCIN LACTOBIONATE
Drug Class | Macrolide Antimicrobial Macrolide |
Physiological Effect | Decreased Sebaceous Gland Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ERYTHROMYCIN LACTOBIONATE
US Patents and Regulatory Information for ERYTHROMYCIN LACTOBIONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | ERYTHROMYCIN LACTOBIONATE | erythromycin lactobionate | INJECTABLE;INJECTION | 062604-002 | Nov 24, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Parenteral | ERYTHROMYCIN LACTOBIONATE | erythromycin lactobionate | INJECTABLE;INJECTION | 063253-001 | Jul 30, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Abraxis Pharm | ERYTHROMYCIN LACTOBIONATE | erythromycin lactobionate | INJECTABLE;INJECTION | 062604-001 | Nov 24, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nexus | ERYTHROMYCIN LACTOBIONATE | erythromycin lactobionate | INJECTABLE;INJECTION | 215290-001 | Feb 14, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.